African-American and older patients with advanced lung cancer can be effectively treated with a new, federally approved therapy, according to researchers from the University of Cincinnati. Such patients are not good candidates for chemotherapy. The findings were published in the journal Libertas Academica. The treatment the researchers focused on is gefitinib, a drug that’s already… Continue reading Improved Quality of LIfe for Lung-Cancer Patients